Tyrosinemia type 1 (HTI) is an inborn error of tyrosine catabolism caused by defective activity of fumarylacetoacetate hydrolase (FAH) and is characterized by progressive liver disease, renal tubular dysfunction, porphyria-like crises and a dramatic improvement in prognosis following treatment with nitisinone. [ Orphanet:882 ]
Synonyms: type I tyrosinemia hepatorenal tyrosinemia fumarylacetoacetate hydrolase deficiency tyrosinemia type I fumarylacetoacetase deficiency FAH deficiency
Term information
- NORD:1811 (MONDO:NORD)
- Orphanet:882 (OMIM:276700)
- DOID:0050726 (MONDO:equivalentTo)
- GARD:2658 (Orphanet:882)
- MedDRA:10069462 (Orphanet:882/e)
- OMIM:276700 (Orphanet:882/e)
- UMLS:C0268490 (Orphanet:882/e)
- NCIT:C98641 (MONDO:equivalentTo)
- SCTID:410056006 (MONDO:equivalentTo)
gard_rare, ordo_disease, rare, nord_rare, orphanet_rare, clingen
http://www.orpha.net/ORDO/Orphanet_882
http://purl.obolibrary.org/obo/DOID_0050726
http://linkedlifedata.com/resource/umls/id/C0268490
https://omim.org/entry/276700
http://purl.obolibrary.org/obo/NCIT_C98641
http://identifiers.org/snomedct/410056006
http://purl.obolibrary.org/obo/MONDO_0020127
http://purl.obolibrary.org/obo/MONDO_0019743
tyrosinemia, type 1
Fah deficiency
TYRSN1
tyrosinemia, type I
tyrosinemia type 1
https://rarediseases.info.nih.gov/diseases/2658/tyrosinemia-type-1
https://search.clinicalgenome.org/kb/conditions/MONDO:0010161